Macquarie Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Hold |
0
| – | -$14K | – | 1774 |
|
|
2022
Q3 | – | Sell |
-580
| Closed | -$13K | – | 2282 |
|
|
2022
Q2 | $13K | Hold |
580
| – | – | ﹤0.01% | 2400 |
|
|
2022
Q1 | $15 | Hold |
580
| – | – | ﹤0.01% | 2438 |
|
|
2021
Q4 | $21K | Hold |
580
| – | – | ﹤0.01% | 2379 |
|
|
2021
Q3 | $25K | Hold |
580
| – | – | ﹤0.01% | 2394 |
|
|
2021
Q2 | $25K | Sell |
580
-98
| -14% | -$4.22K | ﹤0.01% | 2313 |
|
|
2021
Q1 | $28K | Sell |
678
-322
| -32% | -$13.3K | ﹤0.01% | 2202 |
|
|
2020
Q4 | $45K | Hold |
1,000
| – | – | ﹤0.01% | 2062 |
|
|
2020
Q3 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 2023 |
|
|
2020
Q2 | $38K | Hold |
1,000
| – | – | ﹤0.01% | 1990 |
|
|
2020
Q1 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 1886 |
|
|
2019
Q4 | $52K | Sell |
1,000
-1,700
| -63% | -$88.4K | ﹤0.01% | 1847 |
|
|
2019
Q3 | $148K | Sell |
2,700
-3,900
| -59% | -$214K | ﹤0.01% | 1651 |
|
|
2019
Q2 | $268K | Buy |
+6,600
| New | +$268K | ﹤0.01% | 1513 |
|
|
2019
Q1 | – | Sell |
-600
| Closed | -$20K | – | 1656 |
|
|
2018
Q4 | $20K | Sell |
600
-100
| -14% | -$3.33K | ﹤0.01% | 1787 |
|
|
2018
Q3 | $30K | Sell |
700
-300
| -30% | -$12.9K | ﹤0.01% | 1812 |
|
|
2018
Q2 | $32K | Buy |
+1,000
| New | +$32K | ﹤0.01% | 2008 |
|